Sonablate Corp.
Neal Sangani serves as a Board Director at Sonablate Corp., where the company focuses on high intensity focused ultrasound (HIFU) surgical ablation systems. Previously, Neal held the position of VP Corporate Development & FP&A at Meduit, a leader in revenue cycle management solutions. Neal's prior experience at Sonablate includes a role as Chief Financial Officer, and previous positions include VP of Finance at Passport, Equity Research Associate at Goldman Sachs, and Investment Banking Associate at Wells Fargo Securities. Neal holds a B.S. in Finance and Philosophy from NYU Stern School of Business.
This person is not in the org chart
This person is not in any teams
Sonablate Corp.
Our mission is to provide the next generation of sound medicine through proven ablative technologies that precisely deliver care while sparing healthy tissue. This next generation of care involves expanding our current HIFU technologies to treat a range of urological indications that balance treatment effectiveness and quality of life.